The Motley Fool's incorrect reporting may promote some buying this afternoon... lol:Neuren Pharmaceuticals Ltd (ASX: NEU)
Neuren Pharmaceuticals is our first All Ords share to check out. Neuren is having a pretty fabulous day. The company is presently up a decent 1.64% at $8.67 a share.
But this morning, Neuren shares spiked as high as $8.80 each. That is not only a new 52-week high for the Neuren Pharmaceuticals share price, but the highest Neuren has traded since way back in early 2007.
Yes, Neuren is trading at a post-GFC high today. Neuren shares are now up more than 120% year to date. It’s not hard to see why.
In a quarterly update last month, Neuren announced a new drug has been approved by the US Food and Drug Administration (FDA). The company is anticipating revenue from this new drug alone of $112 million in 2023.
- Forums
- ASX - By Stock
- Share Price
The Motley Fool's incorrect reporting may promote some buying...
-
- There are more pages in this discussion • 9,374 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B |
Open | High | Low | Value | Volume |
$14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $13.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.07 | 6644 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.990 |
1 | 300 | 13.970 |
1 | 1432 | 13.950 |
2 | 1230 | 13.900 |
1 | 720 | 13.890 |
Price($) | Vol. | No. |
---|---|---|
14.420 | 175 | 1 |
14.500 | 2985 | 2 |
14.800 | 2850 | 2 |
14.860 | 500 | 1 |
14.960 | 445 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |